A securities class action has been filed against Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) and certain executive officers on behalf of investors who purchased or otherwise acquired Hims securities between August 4, 2025 and July 29, 2026, inclusive (the “Class Period”).
The action, Velanki v. Hims & Hers Health, Inc., et al., Case No. 5:26-cv-09313-EKL, was filed on September 1, 2026 in the U.S. District Court for the Northern District of California. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.
If you acquired Hims securities during the Class Period and suffered a financial loss, contact Kehoe Law Firm to discuss your legal rights without cost or obligation.
What Does the Hims & Hers Health Securities Class Action Allege?
The complaint alleges that Hims made materially false and/or misleading statements and failed to disclose material adverse facts concerning the Company’s business, operations, and prospects.
Specifically, the complaint alleges that Hims shared consumers’ health information with third-party advertising platforms and charged consumers for prescriptions almost immediately after they submitted an intake form, despite telling consumers that they would be able to consult with a medical provider to find a treatment that was “right for them.”
The complaint further alleges that this conduct subjected Hims to regulatory scrutiny and made Hims reasonably likely to incur fees and penalties. As a result, the complaint alleges that defendants’ positive statements about Hims’ business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
The July 29, 2026 FTC Lawsuit and HIMS Stock Decline
According to the complaint, on July 29, 2026, during market hours, the Federal Trade Commission announced that it had filed a lawsuit against Hims alleging that the telehealth provider shared consumers’ sensitive health information with third-party advertising platforms, despite claiming that its services maintained consumers’ privacy, and deceived users about its billing and cancellation practices.
The complaint further alleges that, on this news, HIMS shares declined $4.32, or 14.73%, to close at $25.00 on July 29, 2026, on unusually heavy trading volume.
Review the Hims & Hers Health Securities Class Action Complaint
IMPORTANT: This action is distinct from the earlier Hims & Hers securities litigation, which involves allegations concerning the Company’s relationship with Novo Nordisk and was consolidated as In re Hims & Hers Health, Inc. Securities Litigation, No. 25-cv-05315.
Hims & Hers Health Investors: Contact Kehoe Law Firm
Investors who purchased or otherwise acquired Hims securities during the Class Period and suffered financial losses are encouraged to complete Kehoe Law Firm’s confidential Stockholder Information Request Form or send us a message to discuss their legal rights.
For a free, no-obligation legal evaluation, contact:
Michael Yarnoff, Esq.
(215) 792-6676, Ext. 804
[email protected]
[email protected]
Lead Plaintiff Deadline: November 2, 2026. Investors who wish to seek appointment as lead plaintiff must do so by November 2, 2026. Investors do not need to seek appointment as lead plaintiff to remain potential members of the proposed class or to be eligible to share in any potential recovery.
About Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action law firm representing investors, consumers, and employees in matters involving securities fraud, corporate misconduct, mergers and acquisitions, antitrust violations, whistleblower claims, data breaches, consumer fraud, employment law violations, and retirement-plan mismanagement. Its attorneys have served as lead or co-lead counsel in major securities cases, recovering more than $10 billion for institutional and individual investors.
Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning plaintiffs are not responsible for attorneys’ fees or litigation expenses. Any request for attorneys’ fees and expenses will be subject to court approval.
SEND US A MESSAGE
Contact Us
ADDRESS
Kehoe Law Firm, P.C.
2001 Market Street
Suite 2500
Philadelphia, PA 19103